`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`
`NOVO NORDISK INC. and
`NOVO NORDISK A/S,
`
`Plaintiffs,
`
`v.
`
`VIATRIS INC. and
`MYLAN PHARMACEUTICALS INC.,
`
`Defendants.
`
`
`
`C.A. No. 1:23-cv-13-TSK
`
`
`
`VIATRIS INC. AND MYLAN PHARMACEUTICALS INC.’S
`RULE 7.1 DISCLOSURE STATEMENTS
`
`Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, defendants Viatris Inc. and
`
`Mylan Pharmaceuticals Inc. hereby state that:
`
`1. Mylan Pharmaceuticals Inc. is a wholly-owned subsidiary of Mylan Inc. and operates
`
`as a distinct corporate entity;
`
`2. Mylan Inc. is wholly owned by Viatris Inc., a publicly-traded company, and operates
`
`as a distinct corporate entity; and
`
`3. No publicly-held company owns 10% or more of Viatris Inc.’s stock.
`
`Dated: March 31, 2023
`
`
`
`
`
`
`
`
`
`By: /s/ Brandon M. White
`Brandon M. White (WV Bar No. 14021)
`PERKINS COIE LLP
`700 13th Street NW
`Suite 800
`Washington, DC 20005
`Tel: (202) 654-6200
`bmwhite@perkinscoie.com
`
`Counsel for Viatris Inc. and
`Mylan Pharmaceuticals Inc.
`
`
`
`Case 1:23-cv-00013-TSK Document 26 Filed 03/31/23 Page 2 of 2 PageID #: 386
`
`CERTIFICATE OF SERVICE
`
`I certify that on this 31st day of March 2023, I electronically filed the foregoing “Viatris
`
`Inc. and Mylan Pharmaceuticals Inc.’s Rule 7.1 Disclosure Statements” with the Clerk of the Court
`
`using the CM/ECF system, which will send notice of the same to the following counsel of record:
`
`James F. Companion
`Sandra K. Law
`401 Main Street
`Wheeling, WV 26003
`(304) 233-3390
`jfc@schraderlaw.com
`skl@schraderlaw.com
`
`Nicholas Groombridge
`Josephine Young
`Peter Sandel
`Jenny Wu
`Daniel Klein
`Naz E. Wehrli
`Joshua Reich
`GROOMBRIDGE, WU, BAUGHMAN
`& STONE LLP
`565 Fifth Ave
`Suite 2900
`New York, NY 10017
`
`Counsel for Plaintiffs
`
`
`/s/ Brandon M. White
`Brandon M. White (WV Bar No. 14021)
`PERKINS COIE LLP
`700 13th Street NW
`Suite 800
`Washington, DC 20005
`Tel: (202) 654-6200
`bmwhite@perkinscoie.com
`
`Counsel for Viatris Inc. and
`Mylan Pharmaceuticals Inc.
`
`
`
`
`
`